menu search
Trades24h logo
 Register
close Tap here to search
  1. Home

  2. News

  3. Stock Details

Subscribe To  

  Price Alert   Latest News   Economic Calendar News

MBRX / Moleculin Biotech, Inc. (MBRX) Q3 2022 Earnings Call Transcript

Moleculin Biotech, Inc. (MBRX) Q3 2022 Earnings Call Transcript
Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Walter Klemp – Chairman and Chief Executive Officer Jonathan Foster – Executive Vice President and Chief Financial Officer Conference Call Participants Jonathan Aschoff – ROTH Capital Operator Hello, and welcome to the Moleculin Biotech Inaugural Quarterly Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode. Read More
Hmarkets Logo
Demo chevron_right Live Account chevron_right See Partner Details

Content Topics

Moleculin

Biotech

Inc

MBRX

2022

Earnings

Call

Transcript

Biotech

mbrx

Stock

Posted: Nov 12 2022, 12:57
Author Name: Seeking Alpha
Views: 110859

MBRX News  

Moleculin (MBRX) Posts Update From Lung Cancer Study, Stock Up

By Zacks Investment Research
September 22, 2023

Moleculin (MBRX) Posts Update From Lung Cancer Study, Stock Up

Moleculin (MBRX) completes enrollment in the phase II portion of the development program for its lead candidate, Annamycin, to treat soft tissue sarco more_horizontal

Why Is Moleculin Biotech (MBRX) Stock Is Moving Today?

By InvestorPlace
September 15, 2023

Why Is Moleculin Biotech (MBRX) Stock Is Moving Today?

Moleculin Biotech (NASDAQ: MBRX ) stock is on the move Friday after the clinical-stage pharmaceutical company provided an update to investors. Accord more_horizontal

Moleculin to Present at the H.C. Wainwright 25th Annual Global Investment Conference

By PRNewsWire
September 5, 2023

Moleculin to Present at the H.C. Wainwright 25th Annual Global Investment Conference

HOUSTON , Sept. 5, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical compan more_horizontal

Moleculin Biotech, Inc. (MBRX) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 11, 2023

Moleculin Biotech, Inc. (MBRX) Q2 2023 Earnings Call Transcript

Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q2 2023 Earnings Call Transcript August 11, 2023 8:30 AM ET Company Participants Jenene Thomas - IR Walter Klem more_horizontal

Moleculin to Report Second Quarter Financial Results on August 11, 2023 and Host Conference Call and Webcast

By PRNewsWire
August 3, 2023

Moleculin to Report Second Quarter Financial Results on August 11, 2023 and Host Conference Call and Webcast

HOUSTON , Aug. 3, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company more_horizontal

Moleculin to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

By PRNewsWire
June 13, 2023

Moleculin to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Live webcast fireside chat on Wednesday, June 21 st at 1:30 PM ET HOUSTON , June 13, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (Mo more_horizontal

Moleculin Biotech, Inc. (MBRX) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 11, 2023

Moleculin Biotech, Inc. (MBRX) Q1 2023 Earnings Call Transcript

Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Jenene Thomas - Investor Relation more_horizontal

MBRX Stock Earnings: Moleculin Biotech Misses EPS Estimates

By InvestorPlace
May 11, 2023

MBRX Stock Earnings: Moleculin Biotech Misses EPS Estimates

Moleculin Biotech (NASDAQ: MBRX ) reported first quarter results for 2023. Moleculin Biotech reported a loss per share of 28 cents. more_horizontal

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

©2014-2024 All Rights Reserved. I.C

Hand-crafted & made with Love

logo close

Search within

Pages Search Results: